Growing evidence indicates that drugs of abuse gain control over the individual by usurping glutamate-linked mechanisms of neuroplasticity in reward-related brain regions. Accordingly, we have shown that glutamate α-amino-3-hydroxy-5-methyl-4-isoxazolepropionic acid receptor (AMPAR) activity in the amygdala is required for the positive reinforcing effects of alcohol, which underlie the initial stages of addiction. It is unknown, however, if enhanced AMPAR activity in the amygdala facilitates alcohol self-administration, which is a kernel premise of glutamate hypotheses of addiction. Here, we show that low-dose alcohol (0.6 g/kg/30 minutes) self-administration increases phosphorylation (activation) of AMPAR subtype GluA1 S831 (pGluA1 S831) in the central amygdala (CeA), basolateral amygdala and nucleus accumbens core (AcbC) of selectively bred alcohol-preferring P-rats as compared with behavior-matched (non-drug) sucrose controls. The functional role of enhanced AMPAR activity was assessed via site-specific infusion of the AMPAR positive modulator, aniracetam, in the CeA and AcbC prior to alcohol self-administration. Intra-CeA aniracetam increased alcohol-reinforced but not sucrose-reinforced responding and was ineffective following intra-AcbC infusion. Because GluA1 S831 is a Ca2+/calmodulin-dependent protein kinase II (CaMKII) substrate, we sought to determine if AMPAR regulation of enhanced alcohol self-administration is dependent on CaMKII activity. Intra-CeA infusion of the cell-permeable CaMKII peptide inhibitor myristolated autocamtide-2-related inhibitory peptide (m-AIP) dose-dependently reduced alcohol self-administration. A subthreshold dose of m-AIP also blocked the aniracetam-induced escalation of alcohol self-administration, demonstrating that AMPAR-mediated potentiation of alcohol reinforcement requires CaMKII activity in the amygdala. Enhanced activity of plasticity-linked AMPAR-CaMKII signaling in the amygdala may promote escalated alcohol use via increased positive reinforcement during the initial stages of addiction.
INTRODUCTION
The fundamental behavioral process of positive reinforcement reflects the tendency of all animals, human and non-human, to repeat responses that produce a desired outcome. Accordingly, positive reinforcement mechanisms underlie the repetitive nature of alcohol-seeking behavior during the initial binge/intoxication stages of addiction (Koob & Volkow 2010; Wise & Koob 2014) . At the neurochemical level, evidence suggests that alcohol and other drugs of abuse gain control over behavior by usurping glutamatergic mechanisms of synaptic plasticity in reward circuits (Winder et al. 2002; Kauer & Malenka 2007; Kalivas 2009; McCool et al. 2010) .
Thus, identifying glutamatergic mechanisms of the positive reinforcing effects of alcohol is crucial for understanding the etiology of addiction.
Glutamate is the primary excitatory neurotransmitter in the mammalian brain and plays an essential role in regulating many of the biochemical, physiological and behavioral effects of alcohol (Weight, Lovinger & White 1991; Hodge & Aiken 1996; Siggins et al. 2003; Hodge et al. 2006; Woodward et al. 2006; Gass & Olive 2008; McCool et al. 2010) . Growing evidence indicates that α-amino-3-hydroxy-5-methyl-4-isoxazolepropionic acid (AMPA) glutamate receptors (AMPARs) are important modulators of alcohol self-administration and relapse-like behavior Sanchis-Segura et al. 2006; Wang et al. 2012; Cannady et al. 2013; Salling et al. 2014; Agoglia et al. 2015) . AMPARs are ligand-gated ion channel receptors composed of four subunits (GluA1-4) and mediate rapid excitatory glutamate neurotransmission and regulate synaptic strength (Bredt & Nicoll 2003) . AMPARs are involved in a variety of biological functions, and dysregulation of their activity has been implicated in several neurological, psychiatric and addictive disorders (Zhang & Abdullah 2013) , including alcoholism (Kryger & Wilce 2010) .
Repeated exposure to alcohol leads to AMPARmediated neuroadaptations that enhance synaptic strength in brain regions known to regulate reinforcement and reward processes (Stuber et al. 2008; Wang et al. 2012) , which may promote alcohol consumption through alterations in reinforcement processes. Consistent with this concept, alcohol exposure increases extracellular glutamate levels in reward-related brain regions (Roberto et al. 2004; Gass et al. 2011a; Griffin et al. 2015) . AMPAR GluA1 expression is increased in the striatum after systemically administered alcohol (Wang et al. 2012) and in nucleus accumbens by chronic intermittent consumption (Neasta et al. 2010) . Surface GluA1 is also upregulated in the amygdala after chronic intermittent alcohol vapor exposure (Christian et al. 2012) , and we have shown that both voluntary alcohol drinking (home-cage) and low-dose operant alcohol selfadministration increase GluA1 S831 phosphorylation in the amygdala (Salling et al. 2014) . Thus, AMPAR activity and expression are targets of alcohol in specific brain regions that mediate positive reinforcement.
Glutamate activity in reward-related brain regions has a well-defined role in modulating alcohol consumption, reinforcement and seeking behaviors (Rassnick, Pulvirenti & Koob 1992; Schroeder et al. 2008; Besheer et al. 2010) . Systemic enhancement of glutamate activity at AMPARs increases alcohol self-administration and seeking behavior, which shows that heightened activity at these receptors has the potential to augment alcohol reinforcement processes (Cannady et al. 2013) . Further, AMPAR activity in the amygdala is required for the positive reinforcing effects of alcohol (Salling et al. 2014) . However, it is not known if enhancement of AMPAR signaling in specific reward-related brain regions potentiates the positive reinforcing effects of alcohol, which would be consistent with a role for these systems in the etiology of addiction.
Recent evidence also indicates that drug use, withdrawal and craving are associated with post-translational modification of AMPARs in reward circuits (Wolf 2010) , including phosphorylation by Ca2+/calmodulin-dependent protein kinase II (CaMKII) (Anderson et al. 2008) . CaMKII is a family of Ca 2+ -activated Ser/Thr protein kinases that mediates many intracellular responses in the brain including glutamate release, AMPA receptor function and synaptic plasticity (Hudmon & Schulman 2002; Lisman, Schulman & Cline 2002; Colbran & Brown 2004) . A crucial function of CaMKII is to phosphorylate AMPARs at GluA1 S831 (pGluA1 S831), which leads to potentiation of AMPAR-mediated activity (Barria et al. 1997b; Mammen et al. 1997) . Importantly, elevated glutamate levels after repeated alcohol use (Roberto et al. 2004 ) might activate CaMKII, which then phosphorylates AMPARs at GluA1 S831, promotes membrane insertion and enhances their function (Hudmon & Schulman 2002; Lisman et al. 2002; Colbran & Brown 2004) . We have shown that operant alcohol selfadministration increases expression and phosphorylation of the alpha isoform of CaMKII (CaMKIIα) in mouse amygdala (Salling et al. 2014) and that CaMKII inhibition in the frontal cortex increases the reinforcing effects of alcohol (Faccidomo et al. 2015) . However, it remains to be determined if AMPAR-mediated regulation of the positive reinforcing effects of alcohol requires CaMKII signaling. The goal of the present preclinical studies was to examine the functional role of enhanced glutamate activity at AMPARs, specifically within limbic reward-related brain regions, in the positive reinforcing effects of alcohol. Effects of operant alcohol self-administration were first assessed on AMPAR GluA1 S831 phosphorylation and total GluA1 immunoreactivity (IR) in the nucleus accumbens and amygdala. Guided by these results, we evaluated potential mechanistic regulation of escalated alcohol self-administration via site-specific infusion of the AMPAR positive modulator aniracetam. Finally, we sought to determine if aniracetam-induced increases in alcohol self-administration were dependent on CaMKII activity. These studies were conducted using selectively bred alcohol-preferring rats (P-rats), which are a genetic model of high alcohol preference (Li et al. 1979) . The P-rat line has been shown to fulfill requirements of an animal model of alcoholism (Lester & Freed 1973) , including development of tolerance and dependence through voluntary drinking, and maintaining preference for ethanol over other palatable solutions (Lankford et al. 1991; Kampov-Polevoy et al. 2000) , thus, providing translational relevance of the current findings to individuals with genetic risk for high alcohol preference.
MATERIALS AND METHODS

Animals
Adult male inbred P-rats were pair housed in plexiglass cages and handled daily prior to any training procedures and subsequently single housed following surgeries. All rats had ad libitum home-cage access to food and water. The colony room was maintained on a 12-hour light/dark cycle (lights on at 7 AM), and all experiments were conducted during the light cycle. Body weights for rats in each experiment are shown in Table S1 (Supporting Information). All procedures were conducted in accordance with the National Institute of Health guidelines and approved by the University of North Carolina Institutional Animal Care and Use Committee.
Experiment 1: examination of GluA1 phosphorylation after chronic alcohol self-administration
To examine the effects of operant alcohol self-administration on expression and post-translational modifications of the GluA1 subunit, P-rats were trained to selfadminister either alcohol (15 percent v/v; n = 9) or sucrose (0.4 percent w/v; n = 9) as we describe in Besheer et al. (2010) and Cannady et al. (2013) ; see also Supporting Information Materials and Methods. Brain tissue was collected immediately after the 28th selfadministration session. Using immunohistochemistry, coronal brain sections were processed for phosphorylated GluA1 S831 (pGluA1 S831) or total GluA1. IR in subregions of the amygdala (lateral, LA; basolateral, BLA and central nuclei, CeA), subregions of the nucleus accumbens (core, AcbC and shell, AcbSh; see Supporting Information Methods), the prelimbic region (prefrontal cortex) and the dorsal medial striatum were evaluated as previously described (Cannady et al. 2011; Besheer et al. 2012; Spanos, Besheer & Hodge 2012 ) (Supporting Information Methods).
Experiment 2: examination of site-specific positive modulation of glutamate activity at AMPA receptors on alcohol self-administration
To assess the effects of the AMPA positive modulator aniracetam, alcohol self-administering P-rats received site-specific infusion of aniracetam aimed at the CeA (0, 1 and 3 μg/0.5 μl/side; n = 10) or AcbC (0, 1 and 3, 6 μg/0.5 μl/side; n = 11) immediately prior to operant alcohol (15 percent v/v) self-administration sessions as previously described (Schroeder et al. 2003) ; also see Surgery and Microinjection Methods in the Supporting Information Methods. Drug testing began on the 71st day of self-administration using a within-subjects design in which each aniracetam dose was administered in a randomized order. Following testing, rats in the amygdala group underwent a locomotor assessment to determine whether aniracetam affected general locomotor behavior (Supporting Information Methods). To assess reinforcer specificity, sucrose-trained P-rats (n = 9) received intra-CeA aniracetam (0, 1, 3 and 6 μg/0.5 μl/side) immediately before operant sucrose (0.4 percent w/v) self-administration sessions beginning on the 39th day of self-administration.
Experiment 3: examination of CaMKII involvement in aniracetam-induced potentiation of alcohol self-administration
To test if inhibition of CaMKII phosphorylation reduced alcohol self-administration, P-rats (n = 7) received intraCeA myristolated autocamtide-2-related inhibitory peptide (m-AIP; 0, 5, 10 and 20 μg/0.5 μl/side) immediately before operant alcohol (15 percent v/v) self-administration sessions. A second group of alcohol self-administration trained P-rats (n = 9) received intra-amygdala microinjections of vehicle, aniracetam (1 μg), m-AIP (10 μg) and a cocktail solution consisting of aniracetam (1 μg) + m-AIP (10 μg) to assess whether aniracetam-induced alterations in alcohol self-administration were dependent on CaMKII activity. All drug doses were administered in a randomized order using a within-subjects design beginning on the 35th day of self-administration.
Drugs
Alcohol [95 percent (w/v); Pharmco-AAPER, Shelbyville, KY, USA] was diluted in distilled water to 15 percent (v/v). The AMPAR positive modulator aniracetam (Tocris, Ellisville, MO, USA) and the CaMKII peptide inhibitor m-AIP (Enzo Life Sciences, Farmingdale, NY, USA) were dissolved in 50 percent dimethyl sulfoxide in artificial cerebral spinal fluid. Aniracetam is an allosteric positive modulator of AMPARs that slows deactivation and desensitization of the receptor (Vyklicky, Patneau & Mayer 1991) and has no effect on N-methyl-D-aspartate (NMDA)-mediated synaptic potentials (Boxall & Garthwaite 1995) . Evidence also indicates that aniracetam metabolites enhance AMPAR activity through a CaMKIIdependent mechanism (Nishizaki & Matsumura 2002) . m-AIP is a highly potent cell-permeable inhibitor that selectively inhibits the phosphorylation and activation of CaMKII and has no effect on cyclic adenosine monophosphate (AMP)-dependent protein kinase, protein kinase C and calmodulin-dependent protein kinase IV (Ishida et al. 1995) . The aniracetam and m-AIP dose ranges and were chosen based on demonstrated efficacy in altering behavior in previous studies (Rao, Xiao & Xu 2001; Masuoka, Saito & Kamei 2008; Salling et al. 2014) .
Data analysis
Alcohol (or sucrose) responses were analyzed by one-way repeated measures analysis of variance (RM ANOVA). Cumulative responses and cumulative distance traveled (cm) were analyzed by between groups or RM ANOVA where appropriate. Intake (g/kg) was analyzed by one-way RM ANOVA and calculated based on rat body weight and number of reinforcers delivered. Tukey post hoc comparisons were performed to identify differences between treatments/ treatment groups. T-tests were performed to identify differences in pGluA1 S831 and total GluA1 IR between alcohol and sucrose self-administering rats within brain regions. Statistical significance was determined at P ≤ 0.05.
RESULTS
Experiment 1: examination of GluA1 phosphorylation after chronic alcohol self-administration
To examine chronic alcohol-induced neuroadaptations of AMPAR subunits, immunohistochemistry was performed to assess phosphorylation and expression of the GluA1 subunit in alcohol and sucrose self-administrationtrained P-rats. Mean ± standard error of the mean (SEM) sucrose and alcohol responses across the 28 days were 152.20 ± 28.35 and 110.90 ± 11.31 (corresponding to alcohol intake of 0.60 ± 0.06 g/kg), respectively ( Fig. 1a and b ). This level of alcohol self-administration is consistent with prior studies in P-rats following 30-60 minutes operant sessions (Schroeder, Overstreet & Hodge 2005; Schroeder et al. 2008; Besheer et al. 2010; Cannady et al. 2013) . Two-way RM ANOVA indicated that there was no difference between baseline sucrose-reinforced and alcohol-reinforced responses analyzed over the 28-day period [F(1, 16) = 1.831, P = 0.1948]. These data indicate that operant performance was similar between alcohol and sucrose selfadministering P-rats, allowing for direct comparisons of GluA1 IR between the two self-administration groups.
Amygdala pGluA1 S831 IR was significantly increased in rats with a history of alcohol self-administration in the BLA nucleus (t(16) = 3.671, P = 0.002; Fig. 1c ) and the CeA nucleus (t(16) = 2.173, P = 0.045; Fig. 1d ). In contrast, pGluA1 S831 IR in the LA did not differ between groups (Fig. 1e ). Significant increases in pGluA1 S831 were observed in the AcbC but not the AcbSh (Supporting Information Fig. S1 and Results). pGluA1 S831 IR in the dorsal medial striatum and prefrontal cortex was also examined, and no statistical differences were observed between groups (Table 1) . Additionally, total GluA1 expression was measured to determine if alterations in phosphorylated GluA1 were the result of changes in GluA1 expression, and no significant differences in any of the examined regions were observed (Table 2) . Given a slight trend for an increase in total GluA1 protein following alcohol (Table 2) , the ratio of pGluA1 to total GluA1 was compared within subject for brain regions showing a change in pGluA1. Results indicated that the changes in pGluA1 S831 IR were preserved when assessed relative to total protein: mean ± SEM pGluA1/total GluA1 IR: BLA [sucrose = 0.96 ± 0.14 versus alcohol = 1.4 ± 0.09; t(13) = 2.6, P = 0.01]; CeA [sucrose = 0.98 ± 0.10 versus alcohol = 1.29 ± 0.14; t(13) = 1.8, P = 0.04] and AcbC [sucrose = 1.06 ± 0.12 versus alcohol = 1.66 ± 0.12; t(13) = 3.4, P = 0.002]. Together, these data suggest that operant alcohol self-administration increases GluA1 S831 phosphorylation (e.g. activation) in the amygdala and nucleus accumbens to a greater extent that the nondrug palatable reinforcer, sucrose.
Experiment 2: examination of site-specific positive modulation of glutamate activity at AMPA receptors on alcohol self-administration Baseline self-administration parameters are detailed in Table 3 . To assess whether potentiation of AMPAR activity within limbic brain regions would alter alcohol selfadministration, aniracetam (AMPAR positive modulator) was microinjected into the CeA or AcbC of P-rats trained to self-administer alcohol (15 percent v/v). One-way RM ANOVA indicated that intra-amygdala infusion of aniracetam significantly increased alcohol-reinforced lever responding [F(2, 9) = 4.2, P < 0.03; Fig. 2a] , with a significant increase observed following pretreatment with the lowest aniracetam dose (1 μg) relative to vehicle (P = 0.03). The increase in responding resulted in an increase in alcohol intake following the aniracetam (1 μg) dose (Table 4) . Analysis of cumulative alcoholreinforced responses across the session (Fig. 2b) showed a significant main effect of intra-amygdala aniracetam dose [F(2, 18) = 3.78, P = 0.04] and time [F(5, 45) = 26.88, P < 0.001] as alcohol-reinforced responding increased over the duration of the session. No significant aniracetam dose by time interaction was observed. Water lever responses (vehicle, mean ± SEM = 2.0 ± 0.39) were unchanged by aniracetam. Accurate cannulae placements were verified for all rats in this experiment (Fig. 2c) . Importantly, intra-CeA aniracetam (1 μg) had no effect on locomotor activity in an open field (Supporting Information Fig. S2) , suggesting that the increase in alcohol responses was not due to a nonspecific increase in locomotor behavior.
Examination of alcohol-reinforced responding following intra-AcbC aniracetam (1-6 μg) by one-way RM ANOVA showed a significant effect of accumbens aniracetam dose [F(3, 30 Data represent mean ± standard error of the mean (n = 9/group).
± SEM = 7.3 ± 2.5) were unchanged by aniracetam. As such, this data pattern suggests that in contrast to the functional role of amygdala AMPARs in modulating alcohol self-administration, intra-accumbens aniracetam does not significantly alter alcohol self-administration (Supporting Information Fig. S3a-c) .
To determine if the observed increase in alcohol selfadministration following intra-amygdala aniracetam pretreatment (Fig. 2a) was specific to alcohol, aniracetam was assessed in sucrose (0.4 percent) self-administering P-rats. Intra-amygdala aniracetam had no significant effect on sucrose-reinforced responses across all doses tested (Fig. 2d) . Cumulative sucrose-reinforced responses over time showed a main effect of time [F(5, 40) = 13.53, P < 0.001], but no significant main effect of intra-amygdala aniracetam dose or interaction (Fig. 2e) . Water lever responses (vehicle, mean ± SEM = 5.3 ± 1.9) were unchanged by aniracetam. Accurate cannulae placements were verified for all rats included in this experiment (Fig. 2f) . Together, the results from this experiment show that pharmacological potentiation of intra-amygdala AMPAR activity results in an escalation in alcohol self-administration that is specific to alcohol reinforcement and is not related to a non-specific increase in motor activity. (Fig. 3b) . The reduction in alcoholreinforced responding resulted in a significant decrease in alcohol intake (Table 4) . Water lever responses (vehicle, mean ± SEM = 17.0 ± 7.4) were unchanged by m-AIP. Accurate cannulae placements were verified for all rats included in this experiment (Fig. 3c) .
To determine if aniracetam (1 μg)-induced potentiation of alcohol self-administration (Fig. 2a) depends on CaMKII activity, a cocktail of aniracetam (1 μg) and the highest m-AIP dose that did not alter alcohol selfadministration (10 μg; Fig. 3a) was administered in the amygdala. Significant differences in alcohol-reinforced Data represent mean ± standard error of the mean (n = 9/group). AcbC = nucleus accumbens core; AcbSh = nucleus accumbens shell; BLA = basolateral amygdala; CeA = central amygdala; IR, immunoreactivity; LA = lateral amygdala. Alcohol intake was confirmed at the end of each session and converted to grams/kilogram (g/kg). Data represent mean ± standard error of the mean (n = 7-11/group).
responding were observed after intra-amygdala aniracetam + AIP cocktail infusion [F(3, 24) = 12.52, P < 0.001]. Intra-amygdala aniracetam (1 μg) alone significantly increased alcohol-reinforced responses (P = 0.02; Fig. 3d ) and intake (Table 4) , and m-AIP (10 μg) alone had no effect on alcohol selfadministration, confirming the results of Experiment 2 (Fig. 2a) and the initial assessment in Experiment 3 (Fig. 3a) , respectively. Interestingly, intra-amygdala infusion of the aniracetam + AIP cocktail blocked the aniracetam-induced increase in alcohol-reinforced lever responses (P < 0.001; Fig. 3d ) with a concomitant decrease in alcohol intake (Table 4) (1 μg) beginning at 15 minutes and persisting for the duration of the session (Fig. 3e) . Moreover, this aniracetam-induced escalation in alcohol responses was significantly reduced by m-AIP (aniracetam + AIP cocktail) beginning early and lasting throughout the session (Fig. 3e) . Responses on the water lever (vehicle, mean ± SEM = 13.4 ± 4.1) were unchanged by drug treatment. Accurate cannulae placements were verified for all rats included in this experiment (Fig. 3f) . Importantly, co-administration of aniracetam and m-AIP did not alter locomotor activity in an open field (Supporting Information Fig. S4 ). Together, these data indicate that aniracetam-induced increases in alcohol selfadministration are dependent on amygdala CaMKII activity.
DISCUSSION
Recent evidence indicates that acute systemic enhancement of glutamate activity at AMPARs enhances the positive reinforcing effects of alcohol (Cannady et al. 2013) , which is consistent with the hypothesis that heightened glutamate activity may underlie escalated alcohol use during the initial stages of addiction (Kalivas 2009; Wise & Koob 2014) . In this study, we first sought to determine if the positive reinforcing effects of alcohol are associated with increased AMPAR phosphorylation at GluA1 S831, which is indicative of facilitated receptor activity. Operant alcohol self-administration increased pGluA1 S831 IR in subregions of the amygdala (BLA and CeA) and nucleus accumbens (AcbC) of genetically selected alcoholpreferring P-rats. These results led us to pharmacologically target AMPARs in the CeA and AcbC to assess functional involvement of enhanced AMPAR activity in potentiating alcohol reinforcement. Pharmacological enhancement of AMPAR activity, via local infusion of aniracetam in the CeA, but not AcbC, escalated alcohol self-administration. Moreover, reinforcer specificity was confirmed as intra-CeA aniracetam did not alter selfadministration of the non-drug reward, sucrose. Finally, enhanced AMPAR-mediated facilitation of alcohol reinforcement was dependent on CaMKII as site-specific pretreatment with the CaMKII inhibitor m-AIP in the CeA blocked aniracetam-induced increases in alcohol selfadministration. These data suggest that alcohol-induced upregulation of CaMKII-dependent AMPAR activity in the CeA may underlie the escalated positive reinforcing effects of alcohol that are required for the development of addiction (Wise & Koob 2014) . AMPAR activity is enhanced by several molecular processes, including phosphorylation at GluA1 S831 (Partin, Fleck & Mayer 1996; Pei et al. 2009; Diaz 2010) . Our data show that operant alcohol selfadministration significantly increased GluA1 S831 phosphorylation in the BLA, CeA and AcbC relative to sucrose self-administering controls. This observation is highly significant given that GluA1 S831 phosphorylation is required for long-term potentiation (a molecular correlate of learning and memory) and facilitates trafficking of AMPARs to synaptic sites within the plasma membrane (Barria et al. 1997b; Esteban et al. 2003) , suggesting that chronic alcohol self-administration may potentiate synaptic strength within these two well-characterized brain regions that regulate drug-taking and drug-seeking behaviors. Moreover, given the prominent role of AMPAR GluA1 activity in learning, memory and motivational processes (Maren 2005; Crombag et al. 2008) , it was important to compare potential alcohol-induced changes in GluA1 S831 phosphorylation with a behaviorally matched control group that experienced the same Alcohol self-administrationcomplex operant conditioning and ongoing motor activity. Thus, these data show that alcohol increases AMPAR GluA1 phosphorylation (activation) to a greater extent than the non-drug highly palatable reinforcer sucrose but do not address potential sucrose-only-based or learning-only-based effects.
Changes in phosphorylated protein may reflect altered receptor expression. This seems unlikely, however, as no significant changes were observed in total GluA1 IR after operant alcohol self-administration (Table 2) . These results contrast with studies showing upregulation of total GluA1 in the nucleus accumbens after home-cage alcohol drinking (Neasta et al. 2010; Ary et al. 2012) . This difference may reflect effects of higher doses of alcohol on total GluA1 protein expression following home-cage consumption as compared with the present operant methods that resulted in lower doses. It is also possible that total GluA1 expression was upregulated in the sucrose-trained animals in our study as GluA1 subunit expression/trafficking is altered by sucrose intake (Peng, Ziff & Carr 2011) , which could mask alcohol-induced changes in total GluA1 expression when compared with sucrose. Regardless, alcohol selfadministering P-rats exhibited a greater degree of GluA1 S831 phosphorylation than parallel sucrose controls, which provides novel evidence of low-dose operant alcohol-mediated alterations in AMPAR activation in the amygdala and nucleus accumbens in a genetic model of high alcohol preference.
Given the prominent role of upregulated glutamate activity in the etiology of alcohol addiction (Koob et al. 1998; Stuber et al. 2008; Kryger & Wilce 2010; McCool et al. 2010; Gass et al. 2011b) , we hypothesized that enhanced AMPAR activity in these reward-related brain regions might increase operant alcohol self-administration. Site-specific infusion of the AMPAR positive modulator aniracetam (1 μg) in the CeA increased operant alcohol self-administration indicating that heightened glutamate signaling at AMPARs functionally enhances the reinforcing effects of alcohol. Furthermore, these data suggest that enhanced AMPAR activity in the CeA might have contributed to our previous finding that systemic administration of aniracetam facilitates alcohol self-administration (Cannady et al. 2013) . Interestingly, intra-CeA aniracetam produced an increase in alcohol-reinforced responding at the low dose but failed to alter performance at a single higher dose. This data pattern is consistent with our previous findings following systemically administered aniracetam (Cannady et al. 2013 ) and other studies showing inverted U-shaped dose-response function by aniracetam (Pizzi et al. 1993) , which may indicate off-target effects of high doses. Overall, these are the first results to show that enhanced AMPAR activity in the CeA potentiates the positive reinforcing effects of alcohol.
Pharmacological studies have shown that AMPARs modulate alcohol reinforcement and seeking behavior (Stephens & Brown 1999; Sanchis-Segura et al. 2006; Wang et al. 2012) , and we recently showed that AMPAR activity in the amygdala is required for alcohol positive reinforcement in mice (Salling et al. 2014) . To our knowledge, however, this is the first study to show potentiation of alcohol reinforcement via site-specific activation of the amygdala. Consistent with this result, recent evidence shows that potentiating activity of a specific amygdala-accumbens circuit via optogenetic stimulation drives motivated behavior as evidenced by increases in nose-poke-contingent selfstimulation (Stuber et al. 2011) . Given this evidence, it is plausible that potentiation of amygdala AMPAR activity could alter non-drug reinforcement. However, sucrose self-administration was not altered by intraCeA aniracetam at doses as high as 6 μg per side, which supports prior evidence that enhanced glutamate activity at AMPARs does not alter non-drug reinforcement (Cannady et al. 2013) . Similarly, the effective dose of aniracetam (1 μg/side) did not alter locomotor activity, indicating the absence of non-specific motor activation. Overall, these data suggest that activation of AMPARs in the CeA potentiates the positive reinforcing effects of alcohol, which results in escalated intake. It is important to note, however, that centrally administered drugs can diffuse to adjacent nuclei within or between brain region (Perez de la Mora et al. 2006) , which may have engaged the LA or other proximal structures.
AMPARs are widely expressed in the mammalian brain (Petralia & Wenthold 1992) and may mediate alcohol reinforcement in striatal regions (Wang et al. 2012) ; however, aniracetam infusion in the AcbC had no statistically significant effect on total alcohol-reinforced responses, suggesting a greater mechanistic role of the amygdala. This lack of effect in the nucleus accumbens is somewhat surprising given the well-established role for glutamate activity in this region to modulate alcohol reinforcement. Indeed, intra-accumbens blockade of NMDA and mGluR5 receptors has been shown to attenuate alcohol self-administration (Rassnick et al. 1992; Gass & Olive 2009; Besheer et al. 2010) . It is not clear if varied AMPAR expression between the amygdala and nucleus accumbens contributed to the differential effect of aniracetam on alcohol self-administration. However, this is unlikely as an intra-AcbC aniracetam dose six times higher than that of the effective dose in the amygdala was ineffective at changing behavior. That said, aniracetam infusion in the AcbC produced a dosedependent trend for changes in alcohol-reinforced responding as evidenced by small increases and decreases both in total responding and response rate throughout the session (Supporting Information Results). Based on these trends in behavior and the observed alcoholinduced increase in pGluA1 S831 IR in the AcbC, an alternative explanation is related to microinjection site. Several lines of evidence suggest discrete roles for each accumbens subregion (core versus shell) in mediating the rewarding properties of alcohol (Chaudhri et al. 2010) . Thus, future experimentation examining potentiated AMPAR signaling in the shell may show different effects on alcohol selfadministration.
A highly significant finding of this study is that AMPARmediated escalation of alcohol self-administration in the CeA was dependent on CaMKII. We have shown that operant alcohol self-administration increases phosphorylation of GluA1 S831 and CaMKIIα T286 and that inhibition of AMPAR or CaMKII activity in the amygdala decreases self-administration (Salling et al. 2014) . It was unknown, however, if AMPAR-mediated potentiation of alcohol selfadministration requires CaMKII signaling. To address this question, we first evaluated effects of amygdala infusion of the cell-permeable CaMKII peptide inhibitor m-AIP on operant alcohol self-administration. In agreement with prior results in mice (Salling et al. 2014) , m-AIP dosedependently decreased alcohol self-administration in P-rats. Then, we pretreated rats with a behaviorally inactive dose of m-AIP (10 μg/side) in combination with the effective dose of aniracetam (1 μg/side) in the CeA. m-AIP blocked the aniracetam-induced increase in operant alcohol self-administration and reduced responding and intake. Although it is unclear why alcohol selfadministration following the drug combination was reduced below control levels, these data provide evidence that AMPAR mediated facilitation of alcohol reinforcement by aniracetam functions through a CaMKII-dependent mechanism within the amygdala.
Importantly, when taken together with prior data (Salling et al. 2014) , these results show bidirectional effects on alcohol self-administration by AMPAR activation, or inhibition, in the amygdala, which strongly supports mechanistic regulation. We propose that alcohol selfadministration increases glutamate levels in the amygdala after chronic alcohol exposure (Roberto et al. 2004) leading to phosphorylation of CaMKIIα (Salling et al. 2014) and subsequent activation of AMPARs by CaMKIIα at S831 (Barria, Derkach & Soderling 1997a) . Because CaMKII-dependent AMPAR activity underlies synaptic plasticity (Barria et al. 1997b) , this suggests that moderate alcohol use may mimic plasticity-inducing events in the amygdala (Christian et al. 2012) . Moreover, because CaMKII-dependent AMPAR activity is required for behavioral plasticity, such as learning and memory (Crombag et al. 2008) , these plasticity-like adaptations may promote a gain in alcohol reinforcement learning and function, which supports the development of addiction (Wise & Koob 2014) . Overall, these data suggest that targeted reductions in AMPAR or CaMKII activity may be of therapeutic value for treatment of alcohol use disorders without side effects on non-drug reward processes.
